Filing Details
- Accession Number:
- 0001192482-20-000259
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-27 15:51:37
- Reporting Period:
- 2020-03-26
- Accepted Time:
- 2020-03-27 15:51:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1780097 | Baudax Bio Inc. | BXRX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1285644 | Alfred Altomari | C/O Baudax Bio, Inc. 490 Lapp Road Malvern, PA 19355 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-03-26 | 5,000 | $2.34 | 33,382 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents the weighted average sale price of $2.3442. The range of prices for the sale of these shares was $2.3300 - $2.3500 rounded to the nearest ten-thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.